Bill Kristol
π€ PersonAppearances Over Time
Podcast Appearances
This is like one of the least ambiguous policy areas, broadly speaking, I think, that one could think of. And we're doing what we can to damage ourselves, I think.
Nein, ich glaube, er wΓΌrde das akzeptieren. George H. W. Bush, White House, Vice President Quayle was in charge of something called the Competitiveness Council. One of the things we tried to do was speed up the approval of drugs to sort of make the whole NIH, CDC, FDA process, which is a complicated process, but important, obviously.
Nein, ich glaube, er wΓΌrde das akzeptieren. George H. W. Bush, White House, Vice President Quayle was in charge of something called the Competitiveness Council. One of the things we tried to do was speed up the approval of drugs to sort of make the whole NIH, CDC, FDA process, which is a complicated process, but important, obviously.
Nein, ich glaube, er wΓΌrde das akzeptieren. George H. W. Bush, White House, Vice President Quayle was in charge of something called the Competitiveness Council. One of the things we tried to do was speed up the approval of drugs to sort of make the whole NIH, CDC, FDA process, which is a complicated process, but important, obviously.
You want safe drugs and drugs that are effective, as promised, and so forth. But to speed that up and to streamline it a bit, I guess, that was a more traditional conservative approach.
You want safe drugs and drugs that are effective, as promised, and so forth. But to speed that up and to streamline it a bit, I guess, that was a more traditional conservative approach.
You want safe drugs and drugs that are effective, as promised, and so forth. But to speed that up and to streamline it a bit, I guess, that was a more traditional conservative approach.
critique of big liberal bureaucracies or just big bureaucracy let's just say and it was a reasonable one at the time and i think we did a fair amount that's kind of a technocratic critique right like obama administration had an effort to do that same thing right right and people like us pointed out and i think people pointed this out both on the left and the right and this is very much of a case where you could have a centrist agenda going forward that would be quite you know
critique of big liberal bureaucracies or just big bureaucracy let's just say and it was a reasonable one at the time and i think we did a fair amount that's kind of a technocratic critique right like obama administration had an effort to do that same thing right right and people like us pointed out and i think people pointed this out both on the left and the right and this is very much of a case where you could have a centrist agenda going forward that would be quite you know
critique of big liberal bureaucracies or just big bureaucracy let's just say and it was a reasonable one at the time and i think we did a fair amount that's kind of a technocratic critique right like obama administration had an effort to do that same thing right right and people like us pointed out and i think people pointed this out both on the left and the right and this is very much of a case where you could have a centrist agenda going forward that would be quite you know
healthy, that, you know, why is it that we suspend a lot of these regulations when we really have an emergency and want to produce drugs, whether for the pandemic or for AIDS?
healthy, that, you know, why is it that we suspend a lot of these regulations when we really have an emergency and want to produce drugs, whether for the pandemic or for AIDS?
healthy, that, you know, why is it that we suspend a lot of these regulations when we really have an emergency and want to produce drugs, whether for the pandemic or for AIDS?
I mean, that would suggest that you're not going to act like everything's a super emergency and so you're going to have some more standard procedures, but maybe you do want to look at your standard procedures and make them a little friendlier to the new drugs, even if they're unusual or haven't gone through 22 years of controlled trials and so forth.
I mean, that would suggest that you're not going to act like everything's a super emergency and so you're going to have some more standard procedures, but maybe you do want to look at your standard procedures and make them a little friendlier to the new drugs, even if they're unusual or haven't gone through 22 years of controlled trials and so forth.
I mean, that would suggest that you're not going to act like everything's a super emergency and so you're going to have some more standard procedures, but maybe you do want to look at your standard procedures and make them a little friendlier to the new drugs, even if they're unusual or haven't gone through 22 years of controlled trials and so forth.
So that's all a reasonable debate to have and if we had a healthy politics we would have, but I guess I do, I don't know how much Biden may have done a lot of this behind the scenes. He had responsible people running, I think, these agencies. I do think it was, this is a political point, but I've just been stewing over it recently.
So that's all a reasonable debate to have and if we had a healthy politics we would have, but I guess I do, I don't know how much Biden may have done a lot of this behind the scenes. He had responsible people running, I think, these agencies. I do think it was, this is a political point, but I've just been stewing over it recently.
So that's all a reasonable debate to have and if we had a healthy politics we would have, but I guess I do, I don't know how much Biden may have done a lot of this behind the scenes. He had responsible people running, I think, these agencies. I do think it was, this is a political point, but I've just been stewing over it recently.
The Biden administration's failure to explain, even when it was doing probably some good things, to explain those good things, caused huge damage. It made it seem like the alternative was status quo, big government bureaucracy, no one in charge, no one reforming anything, or Trump.